Cellular microRNA networks regulate host dependency of hepatitis C virus infection

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Li, Qisheng ^a   Lowey, Brianna ^a   Sodroski, Catherine ^a   Krishnamurthy, Siddharth ^a   Alao, Hawwa ^a   Cha, Helen ^a   Chiu, Stephan ^a   El Diwany, Ramy ^a   Ghany, Marc G ^a   Liang, T Jake ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; ASUNAPREVIR; ISOQUINOLINE DERIVATIVE; MESSENGER RNA; SULFONAMIDE;

BIOLOGY; GENOME; GENOMICS; HEPATITIS; INFECTIOUS DISEASE; INHIBITOR; LIFE CYCLE; MOLECULAR ANALYSIS; PHENOTYPE; RNA; VIRAL DISEASE; VIRUS;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE EXPRESSION; GENE REGULATORY NETWORK; GENETIC SCREENING; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIFE CYCLE; NONHUMAN; PHENOTYPE; RNA REPLICATION; TRANSCRIPTOMICS; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS REPLICATION; ADULT; BIOPSY; GENE EXPRESSION PROFILING; GENETICS; GENOMICS; HEPACIVIRUS; HOST PATHOGEN INTERACTION; LIVER; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE; VIROLOGY; YOUNG ADULT;

HEPATITIS C VIRUS;

ADULT; BIOPSY; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENOMICS; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; ISOQUINOLINES; LIVER; MICRORNAS; RNA, MESSENGER; SULFONAMIDES; VIRUS REPLICATION; YOUNG ADULT;

EID: 85035352659     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-01954-x     Document Type: Article

References (58)

1. Bartel, D. P. MicroRNAs: Target recognition and regulatory functions. Cell 136, 215-233 (2009).
2. Fabian, M. R., Sonenberg, N. & Filipowicz, W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351-379 (2010).
3. Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840 (2010).
4. Friedman, R. C., Farh, K. K., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19, 92-105 (2009).
5. Sarnow, P., Jopling, C. L., Norman, K. L., Schutz, S. & Wehner, K. A. MicroRNAs: expression, avoidance and subversion by vertebrate viruses. Nat. Rev. Microbiol. 4, 651-659 (2006).
6. Cullen, B. R. How do viruses avoid inhibition by endogenous cellular microRNAs? PLoS Pathog. 9, e1003694 (2013).
7. Liang, T. J., Rehermann, B., Seeff, L. B. & Hoofnagle, J. H. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 132, 296-305 (2000).
8. Li, Q. et al. A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc. Natl Acad. Sci. USA 106, 16410-16415 (2009).
9. Li, Q. et al. Integrative functional genomics of hepatitis C virus infection identifies host dependencies in complete viral replication cycle. PLoS Pathog. 10, e1004163 (2014).
10. Lupberger, J. et al. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 17, 589-595 (2011).
11. Randall, G. et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl Acad. Sci. USA 104, 12884-12889 (2007).
12. Reiss, S. et al. Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9, 32-45 (2011).
13. Tai, A. W. et al. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 5, 298-307 (2009).
14. Singaravelu, R., Russell, R. S., Tyrrell, D. L. & Pezacki, J. P. Hepatitis C virus and microRNAs: miRed in a host of possibilities. Curr. Opin. Virol. 7, 1-10 (2014).
15. Lanford, R. E. et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327, 198-201 (2010).
16. Janssen, H. L. et al. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368, 1685-1694 (2013).
17. Santhakumar, D. et al. Combined agonist-Antagonist genome-wide functional screening identifies broadly active antiviral microRNAs. Proc. Natl Acad. Sci. USA 107, 13830-13835 (2010).
18. Geiss, G. K. et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 26, 317-325 (2008).
19. Luna, J. M. et al. Hepatitis C virus RNA functionally sequesters miR-122. Cell 160, 1099-1110 (2015).
20. Hou, J. et al. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19, 232-243 (2011).
21. Mullokandov, G. et al. High-Throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat. Methods 9, 840-846 (2012).
22. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
23. Betel, D., Koppal, A., Agius, P., Sander, C. & Leslie, C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 11, R90 (2010).
24. Levy, G. et al. Nuclear receptors control pro-viral and antiviral metabolic responses to hepatitis C virus infection. Nat. Chem. Biol. 12, 1037-1045 (2016).
25. Evans, M. J. et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801-805 (2007).
26. Li, Q. et al. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-To-mesenchymal transition. Proc. Natl Acad. Sci. USA 113, 7620-7625 (2016).
27. Albecka, A. et al. Role of low-density lipoprotein receptor in the hepatitis C virus life cycle. Hepatology 55, 998-1007 (2012).
28. Syed, G. H. et al. Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation. J. Virol. 88, 2519-2529 (2014).
29. Xiao, F. et al. A novel function of microRNA 130a-3p in hepatic insulin sensitivity and liver steatosis. Diabetes 63, 2631-2642 (2014).
30. Singaravelu, R. et al. MicroRNAs regulate the immunometabolic response to viral infection in the liver. Nat. Chem. Biol. 11, 988-993 (2015).
31. Li, Q., Pene, V., Krishnamurthy, S., Cha, H. & Liang, T. J. Hepatitis C virus infection activates an innate pathway involving IKK-Alpha in lipogenesis and viral assembly. Nat. Med. 19, 722-729 (2013).
32. Miyanari, Y. et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell. Biol. 9, 1089-1097 (2007).
33. Penno, A., Hackenbroich, G. & Thiele, C. Phospholipids and lipid droplets. Biochim. Biophys. Acta 1831, 589-594 (2013).
34. Skalsky, R. L. & Cullen, B. R. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 64, 123-141 (2010).
35. Shirasaki, T. et al. MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. J. Virol. 87, 5270-5286 (2013).
36. Singaravelu, R. et al. Hepatitis C virus induced up-regulation of microRNA-27: A novel mechanism for hepatic steatosis. Hepatology 59, 98-108 (2014).
37. Bandiera, S. et al. Hepatitis C virus-induced upregulation of microRNA miR-146a-5p in hepatocytes promotes viral infection and deregulates metabolic pathways associated with liver disease pathogenesis. J. Virol. 90, 6387-6400 (2016).
38. Chen, Y. et al. HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. PLoS Pathog. 9, e1003248 (2013).
39. Meng, F. et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133, 647-658 (2007).
40. McFarland, A. P. et al The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs. Nat. Immunol. 15, 72-79 (2014).
41. Jarret, A. et al. Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling. Nat. Med. 22, 1475-1481 (2016).
42. Lodish, H. F., Zhou, B., Liu, G. & Chen, C. Z. Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol. 8, 120-130 (2008).
43. Zhang, H. et al. Persistent whole-chromosome aneuploidy is generally associated with nascent allohexaploid wheat. Proc. Natl Acad. Sci. USA 110, 3447-3452 (2013).
44. Cullen, B. R., Cherry, S. & tenOever, B. R. Is RNA interference a physiologically relevant innate antiviral immune response in mammals? Cell Host Microbe 14, 374-378 (2013).
45. Li, S. et al. MicroRNA-130a inhibits HCV replication by restoring the innate immune response. J. Viral. Hepat. 21, 121-128 (2014).
46. Cheng, M. et al. High-Throughput profiling of alpha interferon-and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1. J. Virol. 87, 9707-9718 (2013).
47. Pedersen, I. M. et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449, 919-922 (2007).
48. Trobaugh, D. W. et al. RNA viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature 506, 245-248 (2014).
49. Bogerd, H. P. et al. Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs. J. Virol. 88, 8065-8076 (2014).
50. Backes, S. et al. The Mammalian response to virus infection is independent of small RNA silencing. Cell Rep. 8, 114-125 (2014).
51. Whisnant, A. W. et al. In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms. MBio 4, e000193 (2013).
52. Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell. 27, 91-105 (2007).
53. Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791-796 (2005).
54. Kato, T. et al. Production of infectious hepatitis C virus of various genotypes in cell cultures. J. Virol. 81, 4405-4411 (2007).
55. Lindenbach, B. D. et al. Complete replication of hepatitis C virus in cell culture. Science 309, 623-626 (2005).
56. Lavillette, D. et al. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41, 265-274 (2005).
57. Matsumura, T. et al. Amphipathic DNA polymers inhibit hepatitis C virus infection by blocking viral entry. Gastroenterology 137, 673-681 (2009).
58. Masaki, T. et al. Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription. J. Virol. 84, 5824-5835 (2010).